Laird Norton Wetherby Wealth Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $535K | Buy |
|
|||||
|
2024
Q4 | $1.03M | Buy |
|
|||||
|
2024
Q3 | $935K | Sell |
|
|||||
|
2024
Q2 | $1.07M | Sell |
|
|||||
|
2024
Q1 | $1.31M | Sell |
|
|||||
|
2023
Q4 | $1.18M | Buy |
|
|||||
|
2023
Q3 | $1.25M | Buy |
|
|||||
|
2023
Q2 | $1.28M | Sell |
|
|||||
|
2023
Q1 | $1.16M | Buy |
|
|||||
|
2022
Q4 | $746K | Buy |
|
|||||
|
2022
Q3 | $686K | Sell |
|
|||||
|
2022
Q2 | $946K | Buy |
|
|||||
|
2022
Q1 | $338K | Buy |
|
|||||
|
2021
Q4 | $365K | Buy |
|
|||||
|
2021
Q3 | $284K | Buy |
|
|||||
|
2021
Q2 | $231K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $342K | Buy |
|
|||||
|
2019
Q3 | $311K | Sell |
|
|||||
|
2019
Q2 | $279K | Hold |
|
|||||
|
2019
Q1 | $246K | Sell |
|
|||||
|
2018
Q4 | $220K | Hold |
|
|||||
|
2018
Q3 | $278K | Hold |
|
|||||
|
2018
Q2 | $223K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $205K | Hold |
|
|||||
|
2017
Q3 | $200K | Buy |
|